What is Sublocade (buprenorphine) and how is it used?
- have received treatment with an oral transmucosal (used under the tongue or inside the cheek) buprenorphine containing medicine for 7 days and
- are taking a dose that controls withdrawal symptoms for at least seven days.
- Sublocade is part of a complete treatment plan that should include counseling.
What are the most important side effects and other facts about Sublocade (buprenorphine)?
RISK OF SERIOUS HARM OR DEATH WITH INTRAVENOUS ADMINISTRATION; SUBLOCADE RISK EVALUATION AND MITIGATION STRATEGY
- Serious harm or death could result if administered intravenously. Sublocade forms a solid mass upon contact with body fluids and may cause occlusion, local tissue damage, and thrombo-embolic events, including life threatening pulmonary emboli, if administered intravenously.
- Because of the risk of serious harm or death that could result from intravenous self administration, Sublocade is only available through a restricted program called the Sublocade REMS Program. Healthcare settings and pharmacies that order and dispense Sublocade must be certified in this program and comply with the REMS requirements.
- Because of the serious risk of potential harm or death from self-injecting Sublocade into a vein (intravenously), it is only available through a restricted program called the Sublocade REMS Program.
- Sublocade is not available in retail pharmacies.
- Your Sublocade injection will only be given to you by a certified healthcare provider.
- In an emergency, you or your family should tell the emergency medical staff that you are physically dependent on an opioid and are being treated with Sublocade.
- Buprenorphine, the medicine in Sublocade, can cause serious and life-threatening problems, especially if you take or use certain other medicines or drugs. Call your healthcare provider right away or get emergency help if you:
- feel faint or dizzy
- cannot think well or clearly
- have mental changes such as confusion
- have a high body temperature
- have slower breathing than you normally have
- have slowed reflexes
- have severe sleepiness
- feel agitated
- have blurred vision
- have stiff muscles
- have problems with coordination
- have trouble walking
- have slurred speech
These can be signs of an overdose or other serious problems.
What should I avoid while being treated with Sublocade?
- Do not drive, operate heavy machinery, or perform any other dangerous activities until you know how this medicine affects you. Buprenorphine can cause drowsiness and slow reaction times. This may happen more often in the first few days after your injection and when your dose is changed.
- Do not drink alcohol during treatment with Sublocade, as this can lead to slowed breathing, drowsiness, slow reaction time, loss of consciousness or even death.
Other side effects of Sublocade (buprenorphine)
Sublocade can cause serious side effects, including:
- Physical dependence and withdrawal. Your body can develop a physical need for Sublocade (dependence). If you stop receiving Sublocade, you could have opioid withdrawal symptoms such as:
These symptoms may start weeks to months after your last dose of Sublocade
- Liver problems. Call your healthcare provider right away if you notice any of these signs of liver problems:
Your healthcare provider may do tests before and during treatment with Sublocade to check your liver.
- Allergic reaction. Call your healthcare provider or get emergency help right away if you get:
- Decrease in blood pressure. You may feel dizzy when you get up from sitting or lying down.
The most common side effects of Sublocade include:
Long-term (chronic) use of opioids, including Sublocade, may cause fertility problems in males and females. Talk to your healthcare provider if this is a concern for you.
These are not all the possible side effects of Sublocade.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
General information about Sublocade
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. This Medication Guide summarizes important information about Sublocade. If you would like more information talk with your healthcare provider. You can ask your healthcare provider for information that is written for healthcare professionals.
What is the dosage for Sublocade (buprenorphine)?
- You will receive Sublocade by your healthcare provider as an injection just under the skin (subcutaneous) of your stomach (abdomen). You will receive Sublocade monthly (with at least 26 days between doses).
- Sublocade is injected as a liquid. After the injection, Sublocade changes to a solid form called a depot. The depot may be seen or felt as a small bump under your skin at the injection site on your abdomen for several weeks. The depot will get smaller over time.
- Do not try to remove the depot.
- Do not rub or massage the injection site.
- Try not to let belts or clothing waistbands rub against the injection site.
- If you miss a dose of Sublocade, see your healthcare provider to get your Sublocade injection as soon as possible.
Sublocade (buprenorphine) contraindications, pregnancy safety and drug interactions
It is not known if Sublocade is safe or effective in children.
Sublocade is a controlled substance (CIII) because it contains buprenorphine that can be a target for people who abuse prescription medicines or street drugs.
Do not use Sublocade if you are allergic to buprenorphine or any ingredient in the prefilled syringe (ATRIGEL® Delivery System). See the end of this Medication Guide for a list of ingredients in Sublocade.
Sublocade may not be right for you. Before starting Sublocade, tell your healthcare provider about all of your medical conditions, including:
- Trouble breathing or lung problems
- An enlarged prostate gland (men)
- A head injury or brain problem
- Problems urinating
- A curve in your spine that affects your breathing (scoliosis)
- Liver problems
- Gallbladder problems
- Adrenal gland problems
- Addison’s disease
- Low thyroid hormone levels (hypothyroidism)
- A history of alcoholism
- Mental problems such as hallucinations (seeing or hearing things that are not there).
- Are pregnant or plan to become pregnant. If you receive Sublocade while pregnant, your baby may have symptoms of opioid withdrawal at birth.
- Are breastfeeding or plan to breastfeed. Sublocade can pass into your breast milk and may harm your baby. Talk with your healthcare provider about the best way to feed your baby during treatment with Sublocade. Watch your baby for increased drowsiness and breathing problems.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Sublocade may affect the way other medicines work and other medicines may affect how Sublocade works. Some medicines may cause serious or life-threatening medical problems when taken with Sublocade.
- The doses of certain medicines may need to be changed if used during treatment with Sublocade. Do not take any medicine during treatment with Sublocade until you have talked with your healthcare provider. Your healthcare provider will tell you if it is safe to take other medicines during treatment with Sublocade.
- You should not take anxiety medicines or benzodiazepines (such as Valium® or Xanax®), sleeping pills, tranquilizers, muscle relaxants, or sedatives (such as Ambien®), antidepressants, or antihistamines that are not prescribed to you during treatment with Sublocade, as this can lead to slowed breathing, drowsiness, delayed reaction time, loss of consciousness or even death. If a healthcare provider is considering prescribing such a medicine for you, remind the healthcare provider that you are being treated with Sublocade.
- You may have detectable levels of Sublocade in your body for a long period after stopping treatment with Sublocade.
Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist each time you get a new medicine.
Latest Medications News
Daily Health News
Trending on MedicineNet
Medically Reviewed on 4/21/2020
Article courtesy of the U.S. Food and Drug Administration